Skip to main content
GNTA logo

Genenta Science S.p.A.

GNTANASDAQHealthcareBiotechnology

$0.63Today:- (-)1Y −80.49%

As of Oct 22, 2026 close

Market cap
$12.42M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$0.55$10.00
Volume (live)
-
Avg. volume (3M)
60.18K

Genenta Science S.p.A. (GNTA) Stock Price & Financial Analysis

Genenta Science S.p.A. Stock Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Price & Trading Activity
Day's Range$0.63 - $0.66
52-Week High$10.00
52-Week Low$0.55
Open$0.66
Volume (last close)36.97K
Average Volume (3M)60.18K
Technical Indicators
50-Day MA$0.89
200-Day MA$1.07
1-Year Change−80.49%
Size & Valuation
Market Cap12.42M
Shares Outstanding19.71M
Price to Book (P/B)0.51
EV/EBITDA-0.88
Dividend Information
Annual Dividend$0.00
Dividend Yield0.00%

Source: Market prices and company fundamentals. Data as of Oct 22, 2026. Data sources and methodology

Compare GNTA with other stocks

Genenta Science S.p.A. at a Glance

As of the Oct 22, 2026 close, Genenta Science S.p.A. (GNTA) has a market capitalization of $12.42M.

As of its latest reported balance sheet, it holds $6.20M in cash and securities against $8.52M of debt, a net debt position of $2.33M.

Genenta Science S.p.A. does not currently pay a dividend.

The share price is down 80.5% over the past year. At $0.63 (the Oct 22, 2026 close) it sits near the bottom of its 52-week range of $0.55 to $10.00, below its 200-day moving average of $1.07.

Frequently Asked Questions About Genenta Science S.p.A.

What is the current stock price for GNTA?

As of the Oct 22, 2026 close, GNTA stock trades at $0.63. The 52-week range is $0.55–$10.00, with a day range of $0.63–$0.66.

What is the P/E ratio for GNTA?

The P/E ratio (Price-to-Earnings) for GNTA is shown in the Key Statistics section. This valuation metric helps compare Genenta Science S.p.A. to industry peers.

Does GNTA pay dividends?

Genenta Science S.p.A. does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.

What do analysts recommend for GNTA?

Analyst ratings and recommendations for GNTA are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of GNTA?

As of the Oct 22, 2026 close, Genenta Science S.p.A.'s market capitalization is $12.4M, classifying it as a micro-cap company. Genenta Science S.p.A. operates in the Healthcare sector within the Biotechnology industry.